Hundreds of consumers have sued GLP-1 manufacturers Novo Nordisk and Eli Lilly, alleging the drugs increase the risk of a condition causing blindness

Biological preparations that stimulate the immune system to recognize and protect against infectious diseases by inducing a targeted immune response.

Regulations safeguarding retail crypto users from fraud, misleading disclosures, and inadequate asset custody.